Arterial Thrombosis - Pipeline Review, H2 2016

Publisher Name :
Date: 14-Sep-2016
No. of pages: 61
Inquire Before Buying

Global Markets Direct's, ‘Arterial Thrombosis - Pipeline Review, H2 2016', provides an overview of the Arterial Thrombosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Arterial Thrombosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Arterial Thrombosis and features dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Arterial Thrombosis

  • The report reviews pipeline therapeutics for Arterial Thrombosis by companies and universities/research institutes based on information derived from company and industry-specific sources

  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

  • The report reviews key players involved Arterial Thrombosis therapeutics and enlists all their major and minor projects

  • The report assesses Arterial Thrombosis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

  • The report summarizes all the dormant and discontinued pipeline projects

  • The report reviews latest news related to pipeline therapeutics for Arterial Thrombosis

Reasons to buy

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Identify and understand important and diverse types of therapeutics under development for Arterial Thrombosis

  • Identify potential new clients or partners in the target demographic

  • Develop strategic initiatives by understanding the focus areas of leading companies

  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

  • Devise corrective measures for pipeline projects by understanding Arterial Thrombosis pipeline depth and focus of Indication therapeutics

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Arterial Thrombosis - Pipeline Review, H2 2016

Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Arterial Thrombosis Overview 7
Therapeutics Development 8
Pipeline Products for Arterial Thrombosis - Overview 8
Pipeline Products for Arterial Thrombosis - Comparative Analysis 9
Arterial Thrombosis - Therapeutics under Development by Companies 10
Arterial Thrombosis - Therapeutics under Investigation by Universities/Institutes 11
Arterial Thrombosis - Pipeline Products Glance 12
Late Stage Products 12
Clinical Stage Products 13
Early Stage Products 14
Arterial Thrombosis - Products under Development by Companies 15
Arterial Thrombosis - Products under Investigation by Universities/Institutes 16
Arterial Thrombosis - Companies Involved in Therapeutics Development 17
Astellas Pharma Inc. 17
AstraZeneca Plc 18
Bayer AG 19
Bristol-Myers Squibb Company 20
Eisai Co., Ltd. 21
Johnson & Johnson 22
Sanofi 23
Thromboserin Ltd 24
TSRL, Inc. 25
Arterial Thrombosis - Therapeutics Assessment 26
Assessment by Monotherapy Products 26
Assessment by Target 27
Assessment by Mechanism of Action 29
Assessment by Route of Administration 31
Assessment by Molecule Type 33
Drug Profiles 35
AS-1468240 - Drug Profile 35
Product Description 35
Mechanism Of Action 35
R&D Progress 35
ASP-6537 - Drug Profile 36
Product Description 36
Mechanism Of Action 36
R&D Progress 36
BAY-1213790 - Drug Profile 37
Product Description 37
Mechanism Of Action 37
R&D Progress 37
BMS-593214 - Drug Profile 38
Product Description 38
Mechanism Of Action 38
R&D Progress 38
BMS-654457 - Drug Profile 39
Product Description 39
Mechanism Of Action 39
R&D Progress 39
C-3 - Drug Profile 40
Product Description 40
Mechanism Of Action 40
R&D Progress 40
E-5539 - Drug Profile 41
Product Description 41
Mechanism Of Action 41
R&D Progress 41
ER-410660 - Drug Profile 42
Product Description 42
Mechanism Of Action 42
R&D Progress 42
FM-19 - Drug Profile 43
Product Description 43
Mechanism Of Action 43
R&D Progress 43
JNJ-375 - Drug Profile 44
Product Description 44
Mechanism Of Action 44
R&D Progress 44
Peptide to Inhibit PAI-1 for Arterial Thrombosis and Pulmonary Thromboembolism - Drug Profile 45
Product Description 45
Mechanism Of Action 45
R&D Progress 45
PZ-128 - Drug Profile 46
Product Description 46
Mechanism Of Action 46
R&D Progress 46
SAR-216471 - Drug Profile 47
Product Description 47
Mechanism Of Action 47
R&D Progress 47
THL-001 - Drug Profile 48
Product Description 48
Mechanism Of Action 48
R&D Progress 48
ticagrelor - Drug Profile 49
Product Description 49
Mechanism Of Action 49
R&D Progress 49
Arterial Thrombosis - Dormant Projects 57
Arterial Thrombosis - Product Development Milestones 58
Featured News & Press Releases 58
Nov 13, 2014: AstraZeneca announces initiation of development programme for BRILINTA reversal agent 58
Appendix 60
Methodology 60
Coverage 60
Secondary Research 60
Primary Research 60
Expert Panel Validation 60
Contact Us 60
Disclaimer 61

List of Tables

Number of Products under Development for Arterial Thrombosis, H2 2016 8
Number of Products under Development for Arterial Thrombosis - Comparative Analysis, H2 2016 9
Number of Products under Development by Companies, H2 2016 10
Number of Products under Investigation by Universities/Institutes, H2 2016 11
Comparative Analysis by Late Stage Development, H2 2016 12
Comparative Analysis by Clinical Stage Development, H2 2016 13
Comparative Analysis by Early Stage Development, H2 2016 14
Products under Development by Companies, H2 2016 15
Products under Investigation by Universities/Institutes, H2 2016 16
Arterial Thrombosis - Pipeline by Astellas Pharma Inc., H2 2016 17
Arterial Thrombosis - Pipeline by AstraZeneca Plc, H2 2016 18
Arterial Thrombosis - Pipeline by Bayer AG, H2 2016 19
Arterial Thrombosis - Pipeline by Bristol-Myers Squibb Company, H2 2016 20
Arterial Thrombosis - Pipeline by Eisai Co., Ltd., H2 2016 21
Arterial Thrombosis - Pipeline by Johnson & Johnson, H2 2016 22
Arterial Thrombosis - Pipeline by Sanofi, H2 2016 23
Arterial Thrombosis - Pipeline by Thromboserin Ltd, H2 2016 24
Arterial Thrombosis - Pipeline by TSRL, Inc., H2 2016 25
Assessment by Monotherapy Products, H2 2016 26
Number of Products by Stage and Target, H2 2016 28
Number of Products by Stage and Mechanism of Action, H2 2016 30
Number of Products by Stage and Route of Administration, H2 2016 32
Number of Products by Stage and Molecule Type, H2 2016 34
Arterial Thrombosis - Dormant Projects, H2 2016 57

List of Figures

Number of Products under Development for Arterial Thrombosis, H2 2016 8
Number of Products under Development for Arterial Thrombosis - Comparative Analysis, H2 2016 9
Number of Products under Development by Companies, H2 2016 10
Number of Products under Investigation by Universities/Institutes, H2 2016 11
Comparative Analysis by Clinical Stage Development, H2 2016 13
Comparative Analysis by Early Stage Products, H2 2016 14
Assessment by Monotherapy Products, H2 2016 26
Number of Products by Top 10 Targets, H2 2016 27
Number of Products by Stage and Top 10 Targets, H2 2016 27
Number of Products by Top 10 Mechanism of Actions, H2 2016 29
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016 29
Number of Products by Routes of Administration, H2 2016 31
Number of Products by Stage and Routes of Administration, H2 2016 31
Number of Products by Molecule Types, H2 2016 33
Number of Products by Stage and Molecule Types, H2 2016 33
  • Global Thrombin (Human) Market Research Report 2016
    Published: 29-Nov-2016        Price: US 2900 Onwards        Pages: 109
    Notes: Production, means the output of Thrombin (Human) Revenue, means the sales value of Thrombin (Human) This report studies Thrombin (Human) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Baxter - CSL - Bayer - Grifols - Octapharma - Shan......
  • Global Heparin Sales Market Report 2016
    Published: 25-Nov-2016        Price: US 4000 Onwards        Pages: 129
    Notes: Sales, means the sales volume of Heparin Revenue, means the sales value of Heparin This report studies sales (consumption) of Heparin in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Hepalink - Changshan Biochemical - Qianhong Bio-pharma - Opocrin - Pfi......
  • Global Heparin Sodium Market Research Report 2016
    Published: 25-Nov-2016        Price: US 2900 Onwards        Pages: 109
    Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. With the accelerated pace of life and increasing aging population, global morbidity and mortality of cardiovascular and cerebrovascular disease are increased year by year. Heparin sodium is an efficient solution to those diseases. With increasing downstream demand, global heparin sodium production also increased from 133698 Kg in 2011 to 189515 Kg in 2015, with an average increase rate of 9.11%. ......
  • Osteonecrosis - Pipeline Review, H2 2016
    Published: 23-Nov-2016        Price: US 2000 Onwards        Pages: 40
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteonecrosis - Pipeline Review, H2 2016, provides an overview of the Osteonecrosis (Musculoskeletal Disorders) pipeline landscape.Osteonecrosis is bone death caused by poor blood supply to the area. It is most common in the hip and shoulder, but can affect other large joints such as knee, elbow, wrist and ankle. Osteonecrosis can be caused by disease, or a severe trauma, such as a break or dislocation, that a......
  • Thrombocytopenia - Pipeline Review, H2 2016
    Published: 16-Nov-2016        Price: US 2000 Onwards        Pages: 163
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thrombocytopenia - Pipeline Review, H2 2016, provides an overview of the Thrombocytopenia (Hematological Disorders) pipeline landscape.Thrombocytopenia is characterized by an abnormally low amount of platelets Low platelet levels occur due to less production of platelets in the bone marrow, increased breakdown of platelets in the bloodstream or in the spleen or liver. Symptoms include bleeding in the mouth and......
  • Global Heparin Sodium Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 08-Nov-2016        Price: US 3480 Onwards        Pages: 116
    Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Scope of the Report: This report focuses on the Heparin Sodium in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, re......
  • Global Heparin Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 07-Nov-2016        Price: US 3480 Onwards        Pages: 114
    Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machineScope of the Report:This report focuses on the Heparin in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and ......
  • Vasculitis-Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Vasculitis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Vasculitis. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, funding......
  • Deep Vein Thrombosis (DVT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
    Published: 01-Nov-2016        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Deep Vein Thrombosis (DVT)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Deep Vein Thrombosis (DVT) Report is to understand the market and pipeline status of the drugs around the Deep Vein Thrombosis (DVT) to explore the generic development opportunities, licensing opportunities and ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs